Shell Asset Management’s Medtronic MDT Stock Holding History

Shell Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-402,152	Closed	-$29M	–	871
2014 Q4	$29M	Buy	402,152 +23,539	+6%	+$1.64M	0.47%	41
2014 Q3	$23.5M	Buy	378,613 +1,357	+0.4%	+$86.3K	0.36%	55
2014 Q2	$24.1M	Buy	377,256 +31,547	+9%	+$1.92M	0.37%	52
2014 Q1	$21.3M	Buy	345,709 +4,809	+1%	+$280K	0.35%	47
2013 Q4	$19.6M	Sell	340,900 -35,431	-9%	-$2.01M	0.33%	53
2013 Q3	$20M	Buy	376,331 +10,018	+3%	+$539K	0.37%	52
2013 Q2	$18.9M	Buy	+366,313	New	+$18.1M	0.36%	54

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Shell Asset Management's MDT Position: Q1 2015 in Review

Shell Asset Management sold out of Medtronic (MDT) in Q1 2015, closing a stake of 402,152 shares — an estimated $29M sold.

Shell Asset Management first reported a position in MDT in Q2 2013 and held it in 7 quarters. The position peaked at $29M in Q4 2014. 1,245 funds tracked by Wall St. Rank hold MDT as of Q1 2015.

Shell Asset Management reported no remaining Medtronic position as of Q1 2015 after selling out during the quarter.
Shell Asset Management sold 402,152 Medtronic shares in Q1 2015, an estimated $29M.
Shell Asset Management first reported a position in Medtronic in Q2 2013 and held it in 7 quarters.
Shell Asset Management's Medtronic position peaked at $29M in Q4 2014.
1,245 funds tracked by Wall St. Rank held Medtronic as of Q1 2015.

Based on Shell Asset Management's 13F filing for Q1 2015, filed 7 May 2015.